{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:24:58Z","timestamp":1777735498985,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1NR010162-01A1"],"award-info":[{"award-number":["RO1NR010162-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1CA122292-01"],"award-info":[{"award-number":["RO1CA122292-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1CA124481-01"],"award-info":[{"award-number":["RO1CA124481-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"M. D. Anderson Cancer Center","award":["CA 016672"],"award-info":[{"award-number":["CA 016672"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jpainsymman.2012.07.007","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T09:01:01Z","timestamp":1354352461000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Targeted Agent Use in Cancer Patients at the End of Life"],"prefix":"10.1016","volume":"46","author":[{"given":"David","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan Sri","family":"Karuturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberson Cochien","family":"Tanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hye","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2012.07.007_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09339","article-title":"Translating cancer research into targeted therapeutics","volume":"467","author":"de Bono","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jjco\/hyq035","article-title":"Progress in cancer chemotherapy with special stress on molecular-targeted therapy","volume":"40","author":"Saijo","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jpainsymman.2009.05.017","article-title":"Goals of care and end-of-life decision making for hospitalized patients at a Canadian tertiary care cancer center","volume":"38","author":"Hui","year":"2009","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib5","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1200\/JCO.2008.16.3956","article-title":"Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care","volume":"26","author":"Setoguchi","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","article-title":"Identifying potential indicators of the quality of end-of-life cancer care from administrative data","volume":"21","author":"Earle","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib8","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1200\/JCO.2008.20.5096","article-title":"Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006","volume":"27","author":"Tang","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/jpm.2010.0084","article-title":"Targeted therapy at the end of life for patients with lung cancer","volume":"13","author":"Wong","year":"2010","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/cncr.24942","article-title":"Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model","volume":"116","author":"Hui","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib11","unstructured":"Hui D, Kim SH, Kwon JH, et\u00a0al. Access to palliative care before death among patients treated at a comprehensive cancer center. Oncologist. In press."},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1200\/JCO.2004.08.136","article-title":"Trends in the aggressiveness of cancer care near the end of life","volume":"22","author":"Earle","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1001\/jama.299.22.2667","article-title":"The role of chemotherapy at the end of life: \u201cwhen is enough, enough?\u201d","volume":"299","author":"Harrington","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib14","unstructured":"National Cancer Institute. Targeted therapy. IN: National Cancer Institute dictionary of cancer terms. 2012. Available from http:\/\/www.cancer.gov\/dictionary?cdrid=270742. Accessed March 5,\u00a02012."},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/SPC.0b013e32832e4681","article-title":"Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma","volume":"3","author":"Guevremont","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2012.07.007_bib16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.6004\/jnccn.2009.0074","article-title":"NCCN Task Force Report: management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer","volume":"7","author":"Burtness","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ejca.2006.11.016","article-title":"Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors","volume":"43","author":"Galimont-Collen","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ncpcardio1375","article-title":"Vascular complications of selected cancer therapies","volume":"5","author":"Daher","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1345\/aph.1L426","article-title":"Intricacies of bevacizumab-induced toxicities and their management","volume":"43","author":"Gressett","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib20","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1200\/JCO.2009.22.3875","article-title":"Thrombotic events in patients with cancer receiving antiangiogenesis agents","volume":"27","author":"Zangari","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-011-0174-9","article-title":"Common toxicities of mammalian target of rapamycin inhibitors","volume":"6","author":"Soefje","year":"2011","journal-title":"Target Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrclinonc.2009.4","article-title":"Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy","volume":"6","author":"Torino","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/theoncologist.2011-0111","article-title":"Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review","volume":"17","author":"Boers-Doets","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib24","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.2011.35.2393","article-title":"Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs","volume":"29","author":"Amir","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib25","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.2005.01.9208","article-title":"Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy","volume":"24","author":"Grunfeld","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1054\/bjoc.2001.1733","article-title":"Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?","volume":"84","author":"Grunfeld","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.320.7233.469","article-title":"Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study","volume":"320","author":"Christakis","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib28","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1634\/theoncologist.2011-0173","article-title":"The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report","volume":"16","author":"Hui","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib29","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","article-title":"Prognostic factors in advanced cancer patients: evidence-based clinical recommendations\u2013a study by the Steering Committee of the European Association for Palliative Care","volume":"23","author":"Maltoni","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2002.08.138","article-title":"Place of death and its predictors for local patients registered at a comprehensive cancer center","volume":"20","author":"Bruera","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jpm.2009.0166","article-title":"Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center","volume":"13","author":"Hui","year":"2010","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2012.07.007_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1089\/jpm.2005.8.1025","article-title":"Interval between palliative care referral and death among patients treated at a comprehensive cancer center","volume":"8","author":"Cheng","year":"2005","journal-title":"J\u00a0Palliat Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412003703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412003703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:09:14Z","timestamp":1760130554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392412003703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0885392412003703"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.07.007","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Agent Use in Cancer Patients at the End of Life","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}